Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker - PubMed (original) (raw)
Comparative Study
. 2010 Feb 15;49(4):2924-32.
doi: 10.1016/j.neuroimage.2009.11.056. Epub 2009 Dec 4.
Masahiro Fujita, Yota Fujimura, Nobuyo Kimura, Kimberly J Jenko, Pavitra Kannan, Jinsoo Hong, Cheryl L Morse, Sami S Zoghbi, Robert L Gladding, Steven Jacobson, Unsong Oh, Victor W Pike, Robert B Innis
Affiliations
- PMID: 19948230
- PMCID: PMC2832854
- DOI: 10.1016/j.neuroimage.2009.11.056
Comparative Study
Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker
William C Kreisl et al. Neuroimage. 2010.
Abstract
Ten percent of humans lack specific binding of [(11)C]PBR28 to 18 kDa translocator protein (TSPO), a biomarker for inflammation. "Non-binders" have not been reported using another TSPO radioligand, [(11)C]-(R)-PK 11195, despite its use for more than two decades. This study asked two questions: (1) What is the cause of non-binding to PBR28? and (2) Why has this phenomenon not been reported using [(11)C]-(R)-PK 11195?
Methods: Five binders and five non-binders received whole-body imaging with both [(11)C]-(R)-PK 11195 and [(11)C]PBR28. In vitro binding was performed using leukocyte membranes from binders and non-binders and the tritiated versions of the ligand. Rhesus monkeys were imaged with [(11)C]-(R)-PK 11195 at baseline and after blockade of TSPOs.
Results: Using [(11)C]PBR28, uptake in all five organs with high densities of TSPO (lung, heart, brain, kidney, and spleen) was 50% to 75% lower in non-binders than in binders. In contrast, [(11)C]-(R)-PK 11195 distinguished binders and non-binders in only heart and lung. For the in vitro assay, [(3)H]PBR28 had more than 10-fold lower affinity to TSPO in non-binders than in binders. The in vivo specific binding of [(11)C]-(R)-PK 11195 in monkey brain was approximately 80-fold lower than that reported for [(11)C]PBR28.
Conclusions: Based on binding of [(3)H]PK 11195 to leukocyte membranes, both binders and non-binders express TSPO. Non-binding to PBR28 is caused by its low affinity for TSPO in non-binders. Non-binding may be differentially expressed in organs of the body. The relatively low in vivo specific binding of [(11)C]-(R)-PK 11195 may have obscured its detection of non-binding in peripheral organs.
Copyright 2009. Published by Elsevier Inc.
Figures
Figure 1
Human whole body images from one binder (left) and one non-binder (right). Subjects were scanned with both [11C]-(R)-PK 11195 (top) and [11C]PBR28 (bottom). Images were obtained 10 min after injection of radioligand. Color bars represent concentration of radioactivity corrected for body weight and injected dose of activity (standardized uptake values). Note that these values are underestimated since displayed images are averaged in the anterior-posterior dimension.
Figure 2
Human time-activity curves for heart for [11C]-(R)-PK 11195 (A) and [11C]PBR28 (B), and for lung for [11C]-(R)-PK 11195 (C) and [11C]PBR28 (D). For each radioligand, (•) denotes binders and (○) denotes non-binders. Error bars denote standard deviation.
Figure 3
Time-activity curves for heart (A) and lung (B) for two rhesus monkeys using [11C]-(R)-PK 11195 at baseline (•) and after pre-blockade with 5 mg/kg nonradioactive PBR28 (○). For clarity, error bars are not shown. Conc = concentration.
Figure 4
A. Brain time-activity curves for a rhesus monkey using [11C]-(R)-PK 11195 at baseline (•) and after pre-blockade with 5 mg/kg nonradioactive PBR28 (○). B. Plasma concentration of [11C]-(R)-PK 11195 at baseline (•) and after pre-blockade with nonradioactive PBR28 (○). Insert: Plasma concentration curve magnified to demonstrate peak concentrations in plasma in both baseline and pre-blocked conditions.
Similar articles
- 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.
Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, Da Settimo F, Fujita M, Pike VW, Innis RB; Biomarkers Consortium Radioligand Project Team. Ikawa M, et al. J Nucl Med. 2017 Feb;58(2):320-325. doi: 10.2967/jnumed.116.178996. Epub 2016 Nov 17. J Nucl Med. 2017. PMID: 27856631 Free PMC article. - Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA. Owen DR, et al. J Nucl Med. 2011 Jan;52(1):24-32. doi: 10.2967/jnumed.110.079459. Epub 2010 Dec 13. J Nucl Med. 2011. PMID: 21149489 Free PMC article. - Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
Van Weehaeghe D, Babu S, De Vocht J, Zürcher NR, Chew S, Tseng CJ, Loggia ML, Koole M, Rezaei A, Schramm G, Van Damme P, Hooker JM, Van Laere K, Atassi N. Van Weehaeghe D, et al. J Nucl Med. 2020 Nov;61(11):1621-1627. doi: 10.2967/jnumed.119.241059. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169920 Free PMC article. - The potential of carbon-11 and fluorine-18 chemistry: illustration through the development of positron emission tomography radioligands targeting the translocator protein 18 kDa.
Damont A, Roeda D, Dollé F. Damont A, et al. J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):96-104. doi: 10.1002/jlcr.2992. J Labelled Comp Radiopharm. 2013. PMID: 24285315 Review. - Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies.
Chauveau F, Becker G, Boutin H. Chauveau F, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):201-220. doi: 10.1007/s00259-021-05425-w. Epub 2021 Aug 13. Eur J Nucl Med Mol Imaging. 2021. PMID: 34387719 Free PMC article. Review.
Cited by
- TSPO Radioligands for Neuroinflammation: An Overview.
Salerno S, Viviano M, Baglini E, Poggetti V, Giorgini D, Castagnoli J, Barresi E, Castellano S, Da Settimo F, Taliani S. Salerno S, et al. Molecules. 2024 Sep 5;29(17):4212. doi: 10.3390/molecules29174212. Molecules. 2024. PMID: 39275061 Free PMC article. Review. - Preclinical characterization of [18F]D2-LW223: an improved metabolically stable PET tracer for imaging the translocator protein 18 kDa (TSPO) in neuroinflammatory rodent models and non-human primates.
Liao K, Chen JH, Ma J, Dong CC, Bi CY, Gao YB, Jiang YF, Wang T, Wei HY, Hou L, Hu JQ, Wei JJ, Zeng CY, Li YL, Yan S, Xu H, Liang SH, Wang L. Liao K, et al. Acta Pharmacol Sin. 2024 Aug 29. doi: 10.1038/s41401-024-01375-9. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39210042 - Microglial Positron Emission Tomography Imaging In Vivo : Positron Emission Tomography Radioligands: Utility in Research and Clinical Practice.
Ottoy J, De Picker L, Kang MS. Ottoy J, et al. Adv Neurobiol. 2024;37:579-589. doi: 10.1007/978-3-031-55529-9_32. Adv Neurobiol. 2024. PMID: 39207714 Review. - In vivo translocator protein in females with autism spectrum disorder: a pilot study.
Tseng CJ, Canales C, Marcus RE, Parmar AJ, Hightower BG, Mullett JE, Makary MM, Tassone AU, Saro HK, Townsend PH, Birtwell K, Nowinski L, Thom RP, Palumbo ML, Keary C, Catana C, McDougle CJ, Hooker JM, Zürcher NR. Tseng CJ, et al. Neuropsychopharmacology. 2024 Jun;49(7):1193-1201. doi: 10.1038/s41386-024-01859-6. Epub 2024 Apr 13. Neuropsychopharmacology. 2024. PMID: 38615126 Free PMC article. - Does seasonal variation affect the neuroimmune system? A retrospective [11C]PBR28 PET study in healthy individuals.
Ibrahim W, An J, Yang Y, Cosgrove KP, Matuskey D. Ibrahim W, et al. Neurosci Lett. 2024 Apr 1;828:137766. doi: 10.1016/j.neulet.2024.137766. Epub 2024 Apr 5. Neurosci Lett. 2024. PMID: 38583505
References
- Benjamin Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289–300.
- Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW. Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J Med Chem. 2008;51:17–30. - PubMed
- Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH, Imaizumi M, Hong J, Pike VW, Innis RB. Radiation dosimetry and biodistribution in monkey and man of [11C]PBR28: a PET radioligand to image inflammation. J Nucl Med. 2007;48:2072–2079. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Z01 MH002852/ImNIH/Intramural NIH HHS/United States
- Z01 MH002852-04/ImNIH/Intramural NIH HHS/United States
- ZIA MH002795-08/ImNIH/Intramural NIH HHS/United States
- Z01- MH-002852-04/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources